These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17596483)

  • 1. Postprandial hyperglycemia is associated with an increase of blood pressure in type 1 diabetic patients treated with continuous subcutaneous insulin infusion.
    Lepore G; Corsi A; Dodesini AR; Nosari I; Trevisan R
    Diabetes Care; 2007 Jul; 30(7):e60. PubMed ID: 17596483
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of meals with different glycaemic index on postprandial blood glucose response in patients with Type 1 diabetes treated with continuous subcutaneous insulin infusion.
    Parillo M; Annuzzi G; Rivellese AA; Bozzetto L; Alessandrini R; Riccardi G; Capaldo B
    Diabet Med; 2011 Feb; 28(2):227-9. PubMed ID: 21219435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits of a bolus calculator in pre- and postprandial glycaemic control and meal flexibility of paediatric patients using continuous subcutaneous insulin infusion (CSII).
    Shashaj B; Busetto E; Sulli N
    Diabet Med; 2008 Sep; 25(9):1036-42. PubMed ID: 18937673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coverage of postprandial blood glucose excursions with inhaled technosphere insulin in comparison to subcutaneously injected regular human insulin in subjects with type 2 diabetes.
    Rave K; Heise T; Pfützner A; Boss AH
    Diabetes Care; 2007 Sep; 30(9):2307-8. PubMed ID: 17586744
    [No Abstract]   [Full Text] [Related]  

  • 5. Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type 1 diabetic patients.
    Iorio A; Federici MO; Mourvaki E; Ferolla P; Piroddi M; Stabile A; Timi A; Celleno R; Benedetti MM
    Thromb Haemost; 2007 Sep; 98(3):635-41. PubMed ID: 17849053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New developments and prospects in diabetes mellitus].
    Brunetti P
    Recenti Prog Med; 1999 May; 90(5):244-8. PubMed ID: 10380550
    [No Abstract]   [Full Text] [Related]  

  • 8. A 2-way cross-over, open-labeled trial to compare efficacy and safety of insulin Aspart and Novolin R delivered with CSII in 21 Chinese diabetic patients.
    Bi YF; Zhao LB; Li XY; Wang WQ; Sun SY; Chen YH; Hong J; Su TW; Liu JM; Ning G
    Chin Med J (Engl); 2007 Oct; 120(19):1700-3. PubMed ID: 17935674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
    Siebenhofer A; Jeitler K; Berghold A; Horvath K; Pieber TR
    Diabet Med; 2009 Mar; 26(3):311-2; author reply 312-3. PubMed ID: 19317829
    [No Abstract]   [Full Text] [Related]  

  • 10. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
    Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Blood pressure and type 2 diabetes mellitus: impact of the insulin therapy].
    Dakhli S; Lamine S; Lamine F; Trabelsi N; Aouididi F; Zouaoui C; Mami FB; Achour A
    Tunis Med; 2007 Nov; 85(11):945-50. PubMed ID: 19166146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Children and adolescents on intensive insulin therapy maintain postprandial glycaemic control without precise carbohydrate counting.
    Smart CE; Ross K; Edge JA; Collins CE; Colyvas K; King BR
    Diabet Med; 2009 Mar; 26(3):279-85. PubMed ID: 19317823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections.
    ; Nicolucci A; Maione A; Franciosi M; Amoretti R; Busetto E; Capani F; Bruttomesso D; Di Bartolo P; Girelli A; Leonetti F; Morviducci L; Ponzi P; Vitacolonna E
    Diabet Med; 2008 Feb; 25(2):213-20. PubMed ID: 18201210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flexibility of rapid-acting insulin analogues in children and adolescents with diabetes mellitus.
    Danne T
    Clin Ther; 2007; 29 Suppl D():S145-52. PubMed ID: 18191066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible problem with Optipen Pro-1: should diabetic patients continue to use this product?
    Goksen D; Darcan S; Buyukinan M; Kurt E
    Diabetes Care; 2006 Jul; 29(7):1710-1. PubMed ID: 16801608
    [No Abstract]   [Full Text] [Related]  

  • 16. Intensifying insulin therapy in patients with type 2 diabetes.
    Ligthelm RJ; Calle JR
    Am J Med; 2007 Aug; 120(8):e13; author reply e15. PubMed ID: 17679108
    [No Abstract]   [Full Text] [Related]  

  • 17. Sustained IL-1alpha, IL-4, and IL-6 elevations following correction of hyperglycemia in children with type 1 diabetes mellitus.
    Rosa JS; Flores RL; Oliver SR; Pontello AM; Zaldivar FP; Galassetti PR
    Pediatr Diabetes; 2008 Feb; 9(1):9-16. PubMed ID: 18211631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parental fear of hypoglycemia: young children treated with continuous subcutaneous insulin infusion.
    Patton SR; Dolan LM; Henry R; Powers SW
    Pediatr Diabetes; 2007 Dec; 8(6):362-8. PubMed ID: 18036061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of continuous subcutaneous insulin infusion in cystic fibrosis patients with cystic fibrosis-related diabetes awaiting transplantation.
    Reali MF; Festini F; Neri AS; Taccetti G; Repetto T; Chiarelli F; Toni S
    J Cyst Fibros; 2006 Jan; 5(1):67-8. PubMed ID: 16233992
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin glargine and glulisine SoloSTAR pens for the treatment of diabetes.
    Garg S; Kelly WC; Garg S
    Expert Rev Med Devices; 2008 Mar; 5(2):113-23. PubMed ID: 18331174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.